Pruritus Therapeutic Market- Roadmap for Recovery from COVID-19|Increasing Prevalence of Pruritus to Boost Market Growth | Technavio

LONDON–(BUSINESS WIRE)–#GlobalPruritusTherapeuticMarket–Technavio has been monitoring the pruritus therapeutic market and it is poised to grow by USD 3.63 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts

Frequently Asked Questions-

• Based on segmentation by disease type, which is the leading segment in the market?

• The hematologic pruritus is expected to be the leading segment based on disease type in the global market during the forecast period.

• What are the major trends in the market?

• Strong pipeline of expected launches is one of the major trends in the market.

• At what rate is the market projected to grow?

• Growing at a CAGR of almost 6%, the incremental growth of the market is anticipated to be USD 3. (Read more…)63 billion.

• Who are the top players in the market?

• Abbott Laboratories, Allergan Plc, Astellas Pharma Inc., Cipla Inc., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd. are some of the major market participants.

• What are the key market drivers and challenges?

• Increasing prevalence of pruritus is one of the major factors driving the market. However, the poor patient adherence due to inadequate information on drug usage will restrain market growth.

• How big is the North America market?

• The North America region will contribute 39% of market growth.
  

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Allergan Plc, Astellas Pharma Inc., Cipla Inc., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd. are some of the major market participants. The increasing prevalence of pruritus will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Pruritus Therapeutic Market 2020-2024: Segmentation

Pruritus Therapeutic Market is segmented as below:

• Disease Type
  • Renal Pruritus
  • Cholestatic Pruritus
  • Hematologic Pruritus
  • Endocrine Pruritus
  • Oncological Pruritus
• Geography
  • North America
  • Europe
  • APAC
  • ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43185

Pruritus Therapeutic Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The pruritus therapeutic market report covers the following areas:

• Pruritus Therapeutic Market Size
• Pruritus Therapeutic Market Trends
• Pruritus Therapeutic Market Analysis

This study identifies strong pipeline of expected launches as one of the prime reasons driving the pruritus therapeutic market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Pruritus Therapeutic Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist pruritus therapeutic market growth during the next five years
• Estimation of the pruritus therapeutic market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the pruritus therapeutic market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of pruritus therapeutic market vendors

Table of Contents:

Executive Summary

• Market Overview

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 – 2024

Five Forces Analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Disease Type

• Market segments
• Comparison by Disease Type
• Renal pruritus – Market size and forecast 2019-2024
• Cholestatic pruritus – Market size and forecast 2019-2024
• Hematologic pruritus – Market size and forecast 2019-2024
• Endocrine pruritus – Market size and forecast 2019-2024
• Oncological pruritus – Market size and forecast 2019-2024
• Market opportunity by Disease Type

Customer landscape

• Overview

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• APAC – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography

Drivers, Challenges, and Trends

• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Abbott Laboratories
• Allergan Plc
• Astellas Pharma Inc.
• Cipla Inc.
• GlaxoSmithKline Plc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

   

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]
Website: www.technavio.com/